MicroRNA-375 sensitizes tumour necrosis factor-alpha (TNF-α)-induced apoptosis in head and neck squamous cell carcinoma in vitro

International Journal of Oral and Maxillofacial Surgery

Volumn 42, Issue 8, 2013, Pages 949-955

  Wang, J ^a   Huang, H ^a   Wang, C ^a   Liu, X ^a   Hu, F ^a   Liu, M ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

apoptosis; head and neck squamous cell carcinoma; microRNA 375 (miR 375); tumour necrosis factor alpha (TNF )

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE INHIBITOR; FLICE INHIBITORY PROTEIN; MICRORNA 375; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; Z VAD;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME DEGRADATION; GENETIC TRANSFECTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MIMICRY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SENSITIZATION; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; G1 PHASE; HEAD AND NECK NEOPLASMS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICRORNAS; NF-KAPPA B; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879418720     PISSN: 09015027     EISSN: 13990020     Source Type: Journal    
DOI: 10.1016/j.ijom.2013.04.016     Document Type: Article

References (36)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. N. Nohata, T. Hanazawa, N. Kikkawa, M. Mutallip, D. Sakurai, and L. Fujimura Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC) J Hum Genet 56 2011 595 601
3. K. Song, F. Zhu, H.Z. Zhang, and Z.J. Shang Tumor necrosis factor-alpha enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway Exp Cell Res 318 2012 1707 1715
4. C.H. Lee, Y.T. Jeon, S.H. Kim, and Y.S. Song NF-kappaB as a potential molecular target for cancer therapy Biofactors 29 2007 19 35
5. M.C. Arkan, and F.R. Greten IKK- and NF-kappaB-mediated functions in carcinogenesis Curr Top Microbiol Immunol 349 2011 159 169
6. H. Wang, and C.H. Cho Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis Curr Cancer Drug Targets 10 2010 593 599
7. W.C. Cho MicroRNAs as therapeutic targets for lung cancer Expert Opin Ther Targets 14 2012 1005 1008
8. M. Rossbach MicroRNAs in cancer therapy Expert Opin Ther Targets 16 2012 743 745
9. Y. Zeng Principles of micro-RNA production and maturation Oncogene 25 2006 6156 6162
10. B.M. Engels, and G. Hutvagner Principles and effects of microRNA-mediated post-transcriptional gene regulation Oncogene 25 2006 6163 6169
11. L. Hong, Y. Han, Q. Lu, H. Zhang, Q. Zhao, and K. Wu Drug resistance-related microRNAs in esophageal cancer Expert Opin Biol Ther 12 2012 1487 1494
12. A.G. Bader, D. Brown, J. Stoudemire, and P. Lammers Developing therapeutic microRNAs for cancer Gene Ther 18 2011 1121 1126
13. F.H. Sarkar, Y. Li, Z. Wang, D. Kong, and S. Ali Implication of microRNAs in drug resistance for designing novel cancer therapy Drug Resist Updat 13 2010 57 66
14. A.B. Hui, M. Lenarduzzi, T. Krushel, L. Waldron, M. Pintilie, and W. Shi Comprehensive microRNA profiling for head and neck squamous cell carcinomas Clin Cancer Res 16 2010 1129 1139
15. Y. Tsukamoto, C. Nakada, T. Noguchi, M. Tanigawa, L.T. Nguyen, and T. Uchida MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta Cancer Res 70 2010 2339 2349
16. L. Ding, Y. Xu, W. Zhang, Y. Deng, M. Si, and Y. Du MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 Cell Res 20 2010 784 793
17. G.D. Wiens, and G.W. Glenney Origin and evolution of TNF and TNF receptor superfamilies Dev Comp Immunol 35 2011 1324 1335
18. M.N. Poy, L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, and P.E. Macdonald A pancreatic islet-specific microRNA regulates insulin secretion Nature 432 2004 226 230
19. M.N. Poy, J. Hausser, M. Trajkovski, M. Braun, S. Collins, and P. Rorsman Stoffel M. miR-375 maintains normal pancreatic alpha- and beta-cell mass Proc Natl Acad Sci U S A 106 2009 5813 5818
20. C. Bolmeson, J.L. Esguerra, A. Salehi, D. Speidel, L. Eliasson, and C.M. Cilio Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects Biochem Biophys Res Commun 404 2011 16 22
21. J. Szczyrba, E. Nolte, S. Wach, E. Kremmer, R. Stohr, and A. Hartmann Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma Mol Cancer Res 9 2011 791 800
22. X. Li, R. Lin, and J. Li Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer Dig Dis Sci 56 2011 2849 2856
23. O. Giricz, P.A. Reynolds, A. Ramnauth, C. Liu, T. Wang, and L. Stead Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity J Pathol 226 2012 108 119
24. E. Nishikawa, H. Osada, Y. Okazaki, C. Arima, S. Tomida, and Y. Tatematsu Takahashi T. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer Cancer Res 71 2011 6165 6173
25. H. Zhao, L. Zhu, Y. Jin, H. Ji, X. Yan, and X. Zhu miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells Acta Biochim Biophys Sin (Shanghai) 44 2012 177 182
26. S. David, and S.J. Meltzer MicroRNA involvement in esophageal carcinogenesis Curr Opin Pharmacol 11 2011 612 616
27. R. Leidner, L. Ravi, P. Leahy, Y. Chen, B. Bednarchik, and M. Streppel The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis Genes Chromosomes Cancer 51 2012 473 479
28. F. Wang, Y. Li, J. Zhou, J. Xu, C. Peng, and F. Ye Xie X. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1 Am J Pathol 179 2011 2580 2588
29. M. Avissar, B.C. Christensen, K.T. Kelsey, and C.J. Marsit MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma Clin Cancer Res 15 2009 2850 2855
30. M.Y. Siow MicroRNA profiles of oral squamous cell carcinoma (OSCC) using formalin-fixed, paraffin embedded (FFPE) tissue Oral Oncol 47 2011 s117
31. N. Tran, T. McLean, X. Zhang, C.J. Zhao, J.M. Thomson, and C. O'Brien MicroRNA expression profiles in head and neck cancer cell lines Biochem Biophys Res Commun 358 2007 12 17
32. M. Avissar, M.D. McClean, K.T. Kelsey, and C.J. Marsit MicroRNA expression in head and neck cancer associates with alcohol consumption and survival Carcinogenesis 30 2009 2059 2063
33. C.B. Lajer, F.C. Nielsen, L. Friis-Hansen, B. Norrild, R. Borup, and E. Garnaes Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study Br J Cancer 104 2011 830 840
34. T. Harris, L. Jimenez, N. Kawachi, J.B. Fan, J. Chen, and T. Belbin Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas Am J Pathol 180 2012 917 928
35. A.B. Hui, J.P. Bruce, N.M. Alajez, W. Shi, S. Yue, and B. Perez-Ordonez Significance of dysregulated metadherin and microRNA-375 in head and neck cancer Clin Cancer Res 17 2011 7539 7550
36. M. Garofalo, G.L. Condorelli, C.M. Croce, and G. Condorelli MicroRNAs as regulators of death receptors signaling Cell Death Differ 17 2010 200 208